#immunotherapy — Public Fediverse posts
Live and recent posts from across the Fediverse tagged #immunotherapy, aggregated by home.social.
-
DATE: May 28, 2026 at 02:37AM
SOURCE: SCIENCE DAILY MIND-BRAIN FEEDTITLE: Researchers block key protein that helps Parkinson’s spread through the brain
URL: https://www.sciencedaily.com/releases/2026/05/260527023214.htm
A newly identified protein called GPNMB may play a major role in helping Parkinson’s disease spread through the brain. Researchers discovered that immune cells release the protein in response to damaged neurons, creating a vicious cycle that speeds up brain cell degeneration. In early experiments, antibodies that blocked GPNMB stopped the toxic process from spreading between cells.
URL: https://www.sciencedaily.com/releases/2026/05/260527023214.htm
-------------------------------------------------
DAILY EMAIL DIGEST: Email [email protected] -- no subject or message needed.
Private, vetted email list for mental health professionals: https://www.clinicians-exchange.org
Unofficial Psychology Today Xitter to toot feed at Psych Today Unofficial Bot @PTUnofficialBot
NYU Information for Practice puts out 400-500 good quality health-related research posts per week but its too much for many people, so that bot is limited to just subscribers. You can read it or subscribe at @PsychResearchBot
Since 1991 The National Psychologist has focused on keeping practicing psychologists current with news, information and items of interest. Check them out for more free articles, resources, and subscription information: https://www.nationalpsychologist.com
EMAIL DAILY DIGEST OF RSS FEEDS -- SUBSCRIBE: http://subscribe-article-digests.clinicians-exchange.org
READ ONLINE: http://read-the-rss-mega-archive.clinicians-exchange.org
It's primitive... but it works... mostly...
-------------------------------------------------
#psychology #counseling #socialwork #psychotherapy @psychotherapist @psychotherapists @psychology @socialpsych @socialwork @psychiatry #mentalhealth #psychiatry #healthcare #depression #psychotherapist #ParkinsonsDisease #GPNMB #Neuroscience #BrainHealth #Neurodegeneration #ResearchNews #CellDeath #Immunotherapy #Neurology #DiseaseSpread
-
DATE: May 28, 2026 at 02:37AM
SOURCE: SCIENCE DAILY MIND-BRAIN FEEDTITLE: Researchers block key protein that helps Parkinson’s spread through the brain
URL: https://www.sciencedaily.com/releases/2026/05/260527023214.htm
A newly identified protein called GPNMB may play a major role in helping Parkinson’s disease spread through the brain. Researchers discovered that immune cells release the protein in response to damaged neurons, creating a vicious cycle that speeds up brain cell degeneration. In early experiments, antibodies that blocked GPNMB stopped the toxic process from spreading between cells.
URL: https://www.sciencedaily.com/releases/2026/05/260527023214.htm
-------------------------------------------------
DAILY EMAIL DIGEST: Email [email protected] -- no subject or message needed.
Private, vetted email list for mental health professionals: https://www.clinicians-exchange.org
Unofficial Psychology Today Xitter to toot feed at Psych Today Unofficial Bot @PTUnofficialBot
NYU Information for Practice puts out 400-500 good quality health-related research posts per week but its too much for many people, so that bot is limited to just subscribers. You can read it or subscribe at @PsychResearchBot
Since 1991 The National Psychologist has focused on keeping practicing psychologists current with news, information and items of interest. Check them out for more free articles, resources, and subscription information: https://www.nationalpsychologist.com
EMAIL DAILY DIGEST OF RSS FEEDS -- SUBSCRIBE: http://subscribe-article-digests.clinicians-exchange.org
READ ONLINE: http://read-the-rss-mega-archive.clinicians-exchange.org
It's primitive... but it works... mostly...
-------------------------------------------------
#psychology #counseling #socialwork #psychotherapy @psychotherapist @psychotherapists @psychology @socialpsych @socialwork @psychiatry #mentalhealth #psychiatry #healthcare #depression #psychotherapist #ParkinsonsDisease #GPNMB #Neuroscience #BrainHealth #Neurodegeneration #ResearchNews #CellDeath #Immunotherapy #Neurology #DiseaseSpread
-
DATE: May 28, 2026 at 02:37AM
SOURCE: SCIENCE DAILY MIND-BRAIN FEEDTITLE: Researchers block key protein that helps Parkinson’s spread through the brain
URL: https://www.sciencedaily.com/releases/2026/05/260527023214.htm
A newly identified protein called GPNMB may play a major role in helping Parkinson’s disease spread through the brain. Researchers discovered that immune cells release the protein in response to damaged neurons, creating a vicious cycle that speeds up brain cell degeneration. In early experiments, antibodies that blocked GPNMB stopped the toxic process from spreading between cells.
URL: https://www.sciencedaily.com/releases/2026/05/260527023214.htm
-------------------------------------------------
DAILY EMAIL DIGEST: Email [email protected] -- no subject or message needed.
Private, vetted email list for mental health professionals: https://www.clinicians-exchange.org
Unofficial Psychology Today Xitter to toot feed at Psych Today Unofficial Bot @PTUnofficialBot
NYU Information for Practice puts out 400-500 good quality health-related research posts per week but its too much for many people, so that bot is limited to just subscribers. You can read it or subscribe at @PsychResearchBot
Since 1991 The National Psychologist has focused on keeping practicing psychologists current with news, information and items of interest. Check them out for more free articles, resources, and subscription information: https://www.nationalpsychologist.com
EMAIL DAILY DIGEST OF RSS FEEDS -- SUBSCRIBE: http://subscribe-article-digests.clinicians-exchange.org
READ ONLINE: http://read-the-rss-mega-archive.clinicians-exchange.org
It's primitive... but it works... mostly...
-------------------------------------------------
#psychology #counseling #socialwork #psychotherapy @psychotherapist @psychotherapists @psychology @socialpsych @socialwork @psychiatry #mentalhealth #psychiatry #healthcare #depression #psychotherapist #ParkinsonsDisease #GPNMB #Neuroscience #BrainHealth #Neurodegeneration #ResearchNews #CellDeath #Immunotherapy #Neurology #DiseaseSpread
-
DATE: May 28, 2026 at 12:42AM
SOURCE: SCIENCE DAILY PSYCHIATIRY FEEDTITLE: New depression treatment targets the immune system instead of the brain
URL: https://www.sciencedaily.com/releases/2026/05/260527023204.htm
A surprising new approach to depression treatment is showing early promise — not by targeting brain chemicals, but by calming the immune system. In a small clinical trial, researchers found that an anti-inflammatory drug normally used for rheumatoid arthritis appeared to ease symptoms in people with hard-to-treat depression, while also reducing fatigue and anxiety and improving quality of life.
URL: https://www.sciencedaily.com/releases/2026/05/260527023204.htm
-------------------------------------------------
DAILY EMAIL DIGEST: Email [email protected] -- no subject or message needed.
Private, vetted email list for mental health professionals: https://www.clinicians-exchange.org
Unofficial Psychology Today Xitter to toot feed at Psych Today Unofficial Bot @PTUnofficialBot
NYU Information for Practice puts out 400-500 good quality health-related research posts per week but its too much for many people, so that bot is limited to just subscribers. You can read it or subscribe at @PsychResearchBot
Since 1991 The National Psychologist has focused on keeping practicing psychologists current with news, information and items of interest. Check them out for more free articles, resources, and subscription information: https://www.nationalpsychologist.com
EMAIL DAILY DIGEST OF RSS FEEDS -- SUBSCRIBE: http://subscribe-article-digests.clinicians-exchange.org
READ ONLINE: http://read-the-rss-mega-archive.clinicians-exchange.org
It's primitive... but it works... mostly...
-------------------------------------------------
#psychology #counseling #socialwork #psychotherapy @psychotherapist @psychotherapists @psychology @socialpsych @socialwork @psychiatry #mentalhealth #psychiatry #healthcare #depression #psychotherapist #DepressionTreatment #Immunotherapy #AntiInflammatory #MentalHealthNews #DepressionResearch #BrainImmuneConnection #InflammationAndMood #ClinicalTrial #MentalWellness #HardToTreatDepression
-
DATE: May 28, 2026 at 12:42AM
SOURCE: SCIENCE DAILY PSYCHIATIRY FEEDTITLE: New depression treatment targets the immune system instead of the brain
URL: https://www.sciencedaily.com/releases/2026/05/260527023204.htm
A surprising new approach to depression treatment is showing early promise — not by targeting brain chemicals, but by calming the immune system. In a small clinical trial, researchers found that an anti-inflammatory drug normally used for rheumatoid arthritis appeared to ease symptoms in people with hard-to-treat depression, while also reducing fatigue and anxiety and improving quality of life.
URL: https://www.sciencedaily.com/releases/2026/05/260527023204.htm
-------------------------------------------------
DAILY EMAIL DIGEST: Email [email protected] -- no subject or message needed.
Private, vetted email list for mental health professionals: https://www.clinicians-exchange.org
Unofficial Psychology Today Xitter to toot feed at Psych Today Unofficial Bot @PTUnofficialBot
NYU Information for Practice puts out 400-500 good quality health-related research posts per week but its too much for many people, so that bot is limited to just subscribers. You can read it or subscribe at @PsychResearchBot
Since 1991 The National Psychologist has focused on keeping practicing psychologists current with news, information and items of interest. Check them out for more free articles, resources, and subscription information: https://www.nationalpsychologist.com
EMAIL DAILY DIGEST OF RSS FEEDS -- SUBSCRIBE: http://subscribe-article-digests.clinicians-exchange.org
READ ONLINE: http://read-the-rss-mega-archive.clinicians-exchange.org
It's primitive... but it works... mostly...
-------------------------------------------------
#psychology #counseling #socialwork #psychotherapy @psychotherapist @psychotherapists @psychology @socialpsych @socialwork @psychiatry #mentalhealth #psychiatry #healthcare #depression #psychotherapist #DepressionTreatment #Immunotherapy #AntiInflammatory #MentalHealthNews #DepressionResearch #BrainImmuneConnection #InflammationAndMood #ClinicalTrial #MentalWellness #HardToTreatDepression
-
DATE: May 28, 2026 at 12:42AM
SOURCE: SCIENCE DAILY PSYCHIATIRY FEEDTITLE: New depression treatment targets the immune system instead of the brain
URL: https://www.sciencedaily.com/releases/2026/05/260527023204.htm
A surprising new approach to depression treatment is showing early promise — not by targeting brain chemicals, but by calming the immune system. In a small clinical trial, researchers found that an anti-inflammatory drug normally used for rheumatoid arthritis appeared to ease symptoms in people with hard-to-treat depression, while also reducing fatigue and anxiety and improving quality of life.
URL: https://www.sciencedaily.com/releases/2026/05/260527023204.htm
-------------------------------------------------
DAILY EMAIL DIGEST: Email [email protected] -- no subject or message needed.
Private, vetted email list for mental health professionals: https://www.clinicians-exchange.org
Unofficial Psychology Today Xitter to toot feed at Psych Today Unofficial Bot @PTUnofficialBot
NYU Information for Practice puts out 400-500 good quality health-related research posts per week but its too much for many people, so that bot is limited to just subscribers. You can read it or subscribe at @PsychResearchBot
Since 1991 The National Psychologist has focused on keeping practicing psychologists current with news, information and items of interest. Check them out for more free articles, resources, and subscription information: https://www.nationalpsychologist.com
EMAIL DAILY DIGEST OF RSS FEEDS -- SUBSCRIBE: http://subscribe-article-digests.clinicians-exchange.org
READ ONLINE: http://read-the-rss-mega-archive.clinicians-exchange.org
It's primitive... but it works... mostly...
-------------------------------------------------
#psychology #counseling #socialwork #psychotherapy @psychotherapist @psychotherapists @psychology @socialpsych @socialwork @psychiatry #mentalhealth #psychiatry #healthcare #depression #psychotherapist #DepressionTreatment #Immunotherapy #AntiInflammatory #MentalHealthNews #DepressionResearch #BrainImmuneConnection #InflammationAndMood #ClinicalTrial #MentalWellness #HardToTreatDepression
-
In a world first, Israeli scientists find ‘memory’ B cells can target ovarian tumors
Researchers at the Weizmann Institute of Science announced Tuesday they have discovered, in a world first, that specialized…
#NewsBeep #News #US #USA #UnitedStates #UnitedStatesOfAmerica #Health #cancer #CancerResearch #immunetherapy #immunization #immunotherapy #israeliscience #Medicalresearch #ovariancancer #ScientificResearch #WeizmannInstitute
https://www.newsbeep.com/us/666945/ -
In a world first, Israeli scientists find ‘memory’ B cells can target ovarian tumors
Researchers at the Weizmann Institute of Science announced Tuesday they have discovered, in a world first, that specialized…
#NewsBeep #News #US #USA #UnitedStates #UnitedStatesOfAmerica #Health #cancer #CancerResearch #immunetherapy #immunization #immunotherapy #israeliscience #Medicalresearch #ovariancancer #ScientificResearch #WeizmannInstitute
https://www.newsbeep.com/us/666945/ -
First video of immune cells eating live skin cancer in real time
#Science #Biology #CancerResearch #Immunotherapy #SkinCancer #Melanoma #MedicalScience #Health #Medicine #Immunology #Macrophages #ScienceNews #HealthInnovation #ImmuneCells #NewResearch
https://the-14.com/first-video-of-immune-cells-eating-live-skin-cancer-in-real-time/ -
Cytokine-armored CAR-T cell therapy successfully attacks aggressive brain tumors in mice
Scientists at the UCLA Health Jonsson Comprehensive Cancer Center have developed a new cytokine-armored CAR-T cell therapy that helps the…
#NewsBeep #News #Health #Antigen #AU #Australia #Blood #BloodVessel #Brain #Cancer #Cell #Cytokine #glioblastoma #Gliomas #ImmuneSystem #Immunology #Immunotherapy #Preclinical #protein #research #therapy #Tumor #VEGF
https://www.newsbeep.com/au/683845/ -
Cytokine-armored CAR-T cell therapy successfully attacks aggressive brain tumors in mice
Scientists at the UCLA Health Jonsson Comprehensive Cancer Center have developed a new cytokine-armored CAR-T cell therapy that helps the…
#NewsBeep #News #Health #Antigen #AU #Australia #Blood #BloodVessel #Brain #Cancer #Cell #Cytokine #glioblastoma #Gliomas #ImmuneSystem #Immunology #Immunotherapy #Preclinical #protein #research #therapy #Tumor #VEGF
https://www.newsbeep.com/au/683845/ -
https://www.europesays.com/ie/494517/ Tumor microenvironment markers forecast immunotherapy response in rare cancers #cancer #Cell #Éire #Genomic #IE #immunotherapy #Ireland #medicine #pH #Research #Technology #Therapeutics #Tumor
-
CAR-T Cell Therapy Shows Early Promise in Long-Term HIV Control
📰 Original title: Supercharging Immune Cells May Help Control HIV Long-Term
🤖 IA: It's not clickbait ✅
👥 Users: It's not clickbait ✅View full AI summary: https://en.killbait.com/car-t-cell-therapy-shows-early-promise-in-long-term-hiv-control.html?utm_source=mastodon_world&utm_medium=social&utm_campaign=killbait.mastodon_world
-
CAR-T Cell Therapy Shows Early Promise in Long-Term HIV Control
📰 Original title: Supercharging Immune Cells May Help Control HIV Long-Term
🤖 IA: It's not clickbait ✅
👥 Users: It's not clickbait ✅View full AI summary: https://en.killbait.com/car-t-cell-therapy-shows-early-promise-in-long-term-hiv-control.html?utm_source=mastodon_world&utm_medium=social&utm_campaign=killbait.mastodon_world
-
CAR-T Cell Therapy Shows Early Promise in Long-Term HIV Control
📰 Original title: Supercharging Immune Cells May Help Control HIV Long-Term
🤖 IA: It's not clickbait ✅
👥 Users: It's not clickbait ✅View full AI summary: https://en.killbait.com/car-t-cell-therapy-shows-early-promise-in-long-term-hiv-control.html?utm_source=mastodon_social&utm_medium=social&utm_campaign=killbait.mastodon_social
-
https://www.europesays.com/ie/488094/ Scientists Uncover Cancer-Fighting Power of Popular Fatty Liver Drug #cancer #Éire #Health #IE #immunotherapy #Ireland #Liver #oncology #TheUniversityOfHongKong
-
Oncolytic virus therapy is emerging as a transformative cancer treatment, leveraging viruses to attack cancer cells while supporting immune response. Researchers and biotech firms are advancing this promising immunotherapy approach. #Cancer #Immunotherapy
-
Oncolytic virus therapy is emerging as a transformative cancer treatment, leveraging viruses to attack cancer cells while supporting immune response. Researchers and biotech firms are advancing this promising immunotherapy approach. #Cancer #Immunotherapy
-
Oncolytic virus therapy is emerging as a transformative cancer treatment, leveraging viruses to attack cancer cells while supporting immune response. Researchers and biotech firms are advancing this promising immunotherapy approach. #Cancer #Immunotherapy
-
Breakthrough: Scientists discover a hidden brake on immune cells that limits cancer-fighting ability. This internal mechanism offers new immunotherapy opportunities for treatment-resistant patients. #Cancer #Immunotherapy
-
Breakthrough: Scientists discover a hidden brake on immune cells that limits cancer-fighting ability. This internal mechanism offers new immunotherapy opportunities for treatment-resistant patients. #Cancer #Immunotherapy
-
Breakthrough: Scientists discover a hidden brake on immune cells that limits cancer-fighting ability. This internal mechanism offers new immunotherapy opportunities for treatment-resistant patients. #Cancer #Immunotherapy
-
AI-powered research shows thymus gland health dramatically improves cancer immunotherapy outcomes, cutting death risk by nearly half. The immune organ may be key to treatment success. #Cancer #Immunotherapy
-
AI-powered research shows thymus gland health dramatically improves cancer immunotherapy outcomes, cutting death risk by nearly half. The immune organ may be key to treatment success. #Cancer #Immunotherapy
-
AI-powered research shows thymus gland health dramatically improves cancer immunotherapy outcomes, cutting death risk by nearly half. The immune organ may be key to treatment success. #Cancer #Immunotherapy
-
Cancer immunotherapy market set to reach $311.4B by 2031, more than doubling from $144.8B in 2025. Strong research pipelines and supportive regulations driving growth. #Immunotherapy #Oncology
-
Cancer immunotherapy market set to reach $311.4B by 2031, more than doubling from $144.8B in 2025. Strong research pipelines and supportive regulations driving growth. #Immunotherapy #Oncology
-
Cancer immunotherapy market set to reach $311.4B by 2031, more than doubling from $144.8B in 2025. Strong research pipelines and supportive regulations driving growth. #Immunotherapy #Oncology
-
Cancer immunotherapy market set to reach $311.4B by 2031, more than doubling from $144.8B in 2025. Strong research pipelines and supportive regulations driving growth. #Immunotherapy #Oncology
-
New research suggests blocking the body's RNA cleanup mechanism could enhance cancer immunotherapy by preventing tumors from evading immune detection. #Immunotherapy #Cancer
-
New research suggests blocking the body's RNA cleanup mechanism could enhance cancer immunotherapy by preventing tumors from evading immune detection. #Immunotherapy #Cancer
-
New research suggests blocking the body's RNA cleanup mechanism could enhance cancer immunotherapy by preventing tumors from evading immune detection. #Immunotherapy #Cancer
-
New urine test detects bladder cancer DNA and monitors immunotherapy response, offering non-invasive monitoring for post-surgical patients. #BladderCancer #Immunotherapy
-
New urine test detects bladder cancer DNA and monitors immunotherapy response, offering non-invasive monitoring for post-surgical patients. #BladderCancer #Immunotherapy
-
New urine test detects bladder cancer DNA and monitors immunotherapy response, offering non-invasive monitoring for post-surgical patients. #BladderCancer #Immunotherapy
-
https://www.europesays.com/ie/485530/ Researchers develop pH and redox-sensitive systems to reduce immunotherapy toxicity #cancer #CancerImmunotherapy #Cell #Cold #Cytokines #Éire #IE #ImmuneSystem #immunotherapy #Ireland #medicine #Nanoparticles #pH #Research #Science #Technology #Tumor
-
New study reveals how cancer reprograms immune cells to fuel growth, explaining immunotherapy resistance in 80% of patients. A breakthrough that could transform cancer treatment strategies. #Immunotherapy #Cancer
-
New study reveals how cancer reprograms immune cells to fuel growth, explaining immunotherapy resistance in 80% of patients. A breakthrough that could transform cancer treatment strategies. #Immunotherapy #Cancer
-
New study reveals how cancer reprograms immune cells to fuel growth, explaining immunotherapy resistance in 80% of patients. A breakthrough that could transform cancer treatment strategies. #Immunotherapy #Cancer
-
New study of 6,000+ patients suggests earlier timing of immune checkpoint inhibitor therapy improves survival in advanced solid tumors. JAMA Network Open findings could reshape cancer treatment protocols. #Oncology #Immunotherapy
-
New study of 6,000+ patients suggests earlier timing of immune checkpoint inhibitor therapy improves survival in advanced solid tumors. JAMA Network Open findings could reshape cancer treatment protocols. #Oncology #Immunotherapy
-
New study of 6,000+ patients suggests earlier timing of immune checkpoint inhibitor therapy improves survival in advanced solid tumors. JAMA Network Open findings could reshape cancer treatment protocols. #Oncology #Immunotherapy
-
New study of 6,000+ patients suggests earlier timing of immune checkpoint inhibitor therapy improves survival in advanced solid tumors. JAMA Network Open findings could reshape cancer treatment protocols. #Oncology #Immunotherapy
-
GeoVax advances Gedeptin, a gene therapy designed to enhance checkpoint inhibitor response in immunologically cold tumors. Planned neoadjuvant study in head and neck cancer could expand combination immunotherapy options. #Oncology #Immunotherapy
-
GeoVax advances Gedeptin, a gene therapy designed to enhance checkpoint inhibitor response in immunologically cold tumors. Planned neoadjuvant study in head and neck cancer could expand combination immunotherapy options. #Oncology #Immunotherapy
-
GeoVax advances Gedeptin, a gene therapy designed to enhance checkpoint inhibitor response in immunologically cold tumors. Planned neoadjuvant study in head and neck cancer could expand combination immunotherapy options. #Oncology #Immunotherapy
-
GeoVax advances Gedeptin, a gene therapy designed to enhance checkpoint inhibitor response in immunologically cold tumors. Planned neoadjuvant study in head and neck cancer could expand combination immunotherapy options. #Oncology #Immunotherapy
-
https://www.europesays.com/ch/65474/ Roche brings 7-minute lung cancer shot to India #DCGIApproval #immunotherapy #LungCancerTreatment #NonSmallCellLungCancer #Roche #RochePharmaIndia #SubcutaneousInjection #Tecentriq
-
https://www.europesays.com/ch/65327/ Roche Pharma launches Tecentriq® SC, India’s first subcutaneous immunotherapy for lung cancer in India #immunotherapy #launch #LungCancer #Pharma #Roche
-
https://www.europesays.com/ch/65233/ Roche launches subcutaneous lung cancer immunotherapy, cuts delivery time to 7 min #DeliveryTime #immunotherapy #LungCancer #Roche #subcutaneous #Tecentriq